FDA Promises Interchangeability For Alvotech’s 100mg/ml Humira Rival – If It Passes Inspection
April 2023 Approval For AVT02 Adalimumab Biosimilar Hinges On Facility Nod
• By David Wallace
The FDA goal date for AVT02 is 13 April 2023 • Source: Shutterstock 
